Tylenol maker responds to Trump’s acetaminophen claims
NeutralU.S News

Kenvue, the maker of Tylenol, has responded to President Donald Trump's claims that acetaminophen use during pregnancy may increase the risk of autism in children. The company emphasizes that independent scientific research supports the safety of acetaminophen, stating that there is no evidence linking it to autism. This clarification is important as it addresses public concerns and misinformation regarding medication use during pregnancy.
— Curated by the World Pulse Now AI Editorial System